BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8571330)

  • 1. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
    Jen CJ; McIntire LV
    Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
    Lockhart MS; Comp PC; Taylor FB
    J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".
    Beck EA; Shainoff JR; Vogel A; Jackson DP
    J Clin Invest; 1971 Sep; 50(9):1874-84. PubMed ID: 5564395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 4,5-bisphosphate is selectively retained by platelet-fibrin clots formed by thrombin.
    Vickers JD; Kinlough-Rathbone RL; Mustard JF
    Biochem J; 1987 Aug; 245(3):649-53. PubMed ID: 2822029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
    Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
    Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
    Gilliam JM; Berkus V; Taylor FB
    Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin.
    Béguin S; Lindhout T; Hemker HC
    Thromb Haemost; 1989 Feb; 61(1):25-9. PubMed ID: 2749591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
    Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
    Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation.
    Morgenstern E; Ruf A; Patscheke H
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):543-6. PubMed ID: 2133232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
    Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
    Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications.
    Galanakis DK
    Semin Thromb Hemost; 1992 Jan; 18(1):44-52. PubMed ID: 1574716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots.
    Smith DB; Janmey PA; Herbert TJ; Lind SE
    J Lab Clin Med; 1987 Aug; 110(2):189-95. PubMed ID: 3036979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural studies of endothelial and platelet receptor binding of thrombin-colloidal gold probes.
    Handley DA; Chien S
    Eur J Cell Biol; 1986 Jan; 39(2):391-8. PubMed ID: 3007148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.